OBJECTIVE: The lymphocytic infiltrates of minor salivary gland (MSG) lesions of Sjögren syndrome (SS) vary in grade and composition and are generally thought to develop in stepwise manner. Their progression over time is not well defined. METHODS: We studied repetitive MSG biopsy specimens from 28 patients with primary SS. RESULTS: The infiltration grade and prevalence of the major infiltrating cell types (T and B cells, macrophages, dendritic cells, natural killer cells) remained largely unchanged during a median 55 month biopsy time interval followup (quartiles 42-81). CONCLUSION: We found significant disease progression involving the development of mucosa-associated lymphoid tissue lymphoma in patients expressing adverse serologic prognostic factors, such as low serum C4 complement levels and cryoglobulinemia.
OBJECTIVE: The lymphocytic infiltrates of minor salivary gland (MSG) lesions of Sjögren syndrome (SS) vary in grade and composition and are generally thought to develop in stepwise manner. Their progression over time is not well defined. METHODS: We studied repetitive MSG biopsy specimens from 28 patients with primary SS. RESULTS: The infiltration grade and prevalence of the major infiltrating cell types (T and B cells, macrophages, dendritic cells, natural killer cells) remained largely unchanged during a median 55 month biopsy time interval followup (quartiles 42-81). CONCLUSION: We found significant disease progression involving the development of mucosa-associated lymphoid tissue lymphoma in patients expressing adverse serologic prognostic factors, such as low serum C4 complement levels and cryoglobulinemia.
Entities:
Keywords:
AUTOIMMUNE DISEASES; MINOR SALIVARY GLAND LESIONS; SJÖGREN SYNDROME
Authors: Kerry M Leehan; Nathan P Pezant; Astrid Rasmussen; Kiely Grundahl; Jacen S Moore; Lida Radfar; David M Lewis; Donald U Stone; Christopher J Lessard; Nelson L Rhodus; Barbara M Segal; R Hal Scofield; Kathy L Sivils; Courtney Montgomery; A Darise Farris Journal: Clin Exp Rheumatol Date: 2017-10-23 Impact factor: 4.473
Authors: E Apostolou; E K Kapsogeorgou; O D Konsta; I Giotakis; M I Saridaki; E Andreakos; A G Tzioufas Journal: Clin Exp Immunol Date: 2016-10-04 Impact factor: 4.330
Authors: Brith Bergum; Catalin Koro; Nicolas Delaleu; Magne Solheim; Annelie Hellvard; Veronika Binder; Roland Jonsson; Valeria Valim; Daniel S Hammenfors; Malin V Jonsson; Piotr Mydel Journal: Ann Rheum Dis Date: 2015-09-08 Impact factor: 19.103